Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...

When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...

Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms ...

The immune system provides constant surveillance for the body, aiming to spot and eliminate disease-causing microbes or ...

Among patients with relapsed or refractory multiple myeloma, Tecvayli (teclistamab-cqyv) monotherapy was associated with a 71 ...

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the ...